These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26697673)

  • 1. Function and mechanism of neurotensin (NTS) and its receptor 1 (NTSR1) in occurrence and development of tumors.
    Hu HR; Dong Z; Yi L; He XY; Zhang YL; Liu YL; Cui HJ
    Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(13):2524-36. PubMed ID: 26697673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
    Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
    Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenetic history, pharmacological features, and signal transduction of neurotensin receptors in vertebrates.
    Hwang JI; Kim DK; Kwon HB; Vaudry H; Seong JY
    Ann N Y Acad Sci; 2009 Apr; 1163():169-78. PubMed ID: 19456337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.
    Rodríguez Y; Almeida TA; Valladares F; Báez D; Montes de Oca F; García C; Dorta I; Hernández M; Reyes R; Bello AR
    Biol Reprod; 2010 Oct; 83(4):641-7. PubMed ID: 20592307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer.
    Zhu S; Tian H; Niu X; Wang J; Li X; Jiang N; Wen S; Chen X; Ren S; Xu C; Chang C; Flores-Morales A; Shang Z; Sun Y; Niu Y
    Oncogene; 2019 Jun; 38(24):4875-4884. PubMed ID: 30770901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
    Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
    Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.
    Dupouy S; Mourra N; Doan VK; Gompel A; Alifano M; Forgez P
    Biochimie; 2011 Sep; 93(9):1369-78. PubMed ID: 21605619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides.
    Kim ER; Mizuno TM
    Neurosci Lett; 2010 Jan; 468(1):64-7. PubMed ID: 19857548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.
    Moody TW; Ramos-Alvarez I; Jensen RT
    Peptides; 2022 Oct; 156():170858. PubMed ID: 35932909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
    Zhang Y; Zhu S; Yi L; Liu Y; Cui H
    Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
    Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
    Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Kim JT; Weiss HL; Evers BM
    Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin Receptor Allosterism Revealed in Complex with a Biased Allosteric Modulator.
    Krumm BE; DiBerto JF; Olsen RHJ; Kang HJ; Slocum ST; Zhang S; Strachan RT; Huang XP; Slosky LM; Pinkerton AB; Barak LS; Caron MG; Kenakin T; Fay JF; Roth BL
    Biochemistry; 2023 Apr; 62(7):1233-1248. PubMed ID: 36917754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells.
    Heakal Y; Kester M
    Mol Cancer Res; 2009 May; 7(5):724-34. PubMed ID: 19435815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist.
    Lückmann M; Holst B; Schwartz TW; Frimurer TM
    Mol Inform; 2016 Jan; 35(1):19-24. PubMed ID: 27491650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the agonist-bound neurotensin receptor.
    White JF; Noinaj N; Shibata Y; Love J; Kloss B; Xu F; Gvozdenovic-Jeremic J; Shah P; Shiloach J; Tate CG; Grisshammer R
    Nature; 2012 Oct; 490(7421):508-13. PubMed ID: 23051748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.